Valicare extends GxP expertise

▴ Valicare extends GxP expertise
A new focus is on consulting services for the transition of products from the development phase to the GMP compliant manufacturing of investigational medicinal products

Valicare GmbH, a wholly owned subsidiary of Syntegon, now offers additional services along the entire product life cycle of pharmaceutically and biotechnologically produced drugs. A new focus is on consulting services for the transition of products from the development phase to the GMP compliant manufacturing of investigational medicinal products.These services are complemented by the presentation and assessment of market-specific requirements, investigational drug management and the necessary regulatory interactions.

To underline the extension of the service portfolio, Valicare has recruited Dr Christin Erbach to join the expert team of engineers and scientists as a Senior GMP Consultant. Dr Erbach has more than ten years of clinical service experience along with deep knowledge in quality management and legal pharmaceutical requirements. She also successfully supported pharmaceutical businesses during their establishment phase.

“Her specialized knowledge in the area of clinical services combined with her legal background is an outstanding addition to Valicare’s consultancy business,” says Dr Hans-Georg Eckert, site manager of Valicare in Frankfurt. “She will strengthen our competenciesregarding the first GMP steps and the legal requirements for clinical products, addressing special needs for each development stage. This way, we are able to extend our approach of accompanying products along their complete life cycle.”

Valicare is significantly expanding its GxP and consultancy services for the pharma, biotech and ATMP industries to fulfill individual demands regarding products and projects from development to market release. As far as ATMPs are concerned, the company already supports customers in meeting regulatory requirements for more and more individual therapies and minimizing associated risks.Valicare also offers complete solutions for the production of ATMPs as well as consulting and supporting services, right through to the production of the first investigational medicinal products.

Valicare GmbH has been a GMP consulting service provider with headquarter in Frankfurt/Main, Germany, since 2002. More than 100 natural scientists and engineers support the pharma, biotech and medical technology industry with a broad portfolio of GxP services. Valicare is a subsidiary of Syntegon, a global supplier of process and packaging technology for the pharmaceutical and food industries, Valicare is a renowned expert for GxP compliance support with a special focus on aseptic filling processes and ATMP manufacturing. More than 1,500 GMP projects make Valicare an expert in this field.

Tags : #ValicareGmbH #Syntegon #LatestPharmaNews22ndOct #DrChristinErbach #Germany #DrHansGeorgEckert

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

Parental tips for keeping teens safe onlineFebruary 08, 2023
The Symptoms and Causes of Anorexia NervosaFebruary 08, 2023
Pervez Musharraf President of Pakistan died of Amyloidosis, a rare diseaseFebruary 07, 2023
National AIDS Control Program – Importance of knowing HIV statusFebruary 06, 2023
FGM : Let's End the practice that hurts girls and womenFebruary 06, 2023
World Cancer Day - Most prominent cancers of IndiaFebruary 04, 2023
World Cancer Day - Never Give up the HopeFebruary 04, 2023
Salt - Effects of Consuming too much SaltFebruary 03, 2023
India’s mission of eliminating dog-mediated rabies by 2030February 03, 2023
Climate change and healthFebruary 02, 2023
Rheumatoid Arthritis Awareness Day: Let's Create AwarenessFebruary 02, 2023
Importance of early diagnosis and cancer screeningFebruary 01, 2023
Union Budget 2023-2024: What's for Healthcare?February 01, 2023
Nourish You has raised $2million to Invest in R&D and Strengthen its Market Presence.February 01, 2023
Enzene Biosciences has raised $50million to expand in its core market of India and US.January 31, 2023
Enzene Biosciences has raised $50million to expand in its core market of India and US.January 31, 2023
World Leprosy Day 2023 – Act now, End LeprosyJanuary 30, 2023
The Warrior Expedition 32/26: A Mission to Encourage Youths to join Indian ForcesJanuary 30, 2023
Mental health – What’s normal and what’s abnormalJanuary 30, 2023
Big Data in Healthcare and Its BenefitsJanuary 27, 2023